Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06VPE
|
|||
| Former ID |
DIB016309
|
|||
| Drug Name |
Lu-AA38466
|
|||
| Synonyms |
Ion channel modulator (neurological disease), H Lundbeck
Click to Show/Hide
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Discontinued in Phase 1 | [1] | |
| Company |
H Lundbeck A/S
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ion channel unspecific (IC) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029333) | |||
| REF 2 | Lundbeck is developing new and promising pharmaceuticals for the treatment of depression, anxiety and psychotic disorders and for new disease areas such as stroke and alcohol dependence. Pipeline report of Lundbeck in 2008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.